September 19, 2014 11:02 PM ET

Pharmaceuticals

Company Overview of Slate Pharmaceuticals, Inc.

Company Overview

Slate Pharmaceuticals, Inc. acquires, develops, and commercializes products for the diseases of maturing men and women. It offers specialized subcutaneous pellet delivery of hormones. The company offers its products in the United States. Slate Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Durham, North Carolina. As of December 29, 2011, Slate Pharmaceuticals, Inc. operates as a subsidiary of Actient Pharmaceuticals, LLC.

318 Blackwell Street

Suite 240

Durham, NC 27701

United States

Founded in 2007

Phone:

919-682-8800

Fax:

919-682-8809

Key Executives for Slate Pharmaceuticals, Inc.

Founder
Age: 63
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Vaxess Technologies Inc. United States
Advanced Bio-Technologies, Inc. United States
Infusion Treatment Centers, Inc. United States
Kelatron Corporation United States
Validus Pharmaceuticals LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Slate Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.